Elevance Health (ELV) Financials: Revenue & Earnings
$90.97B
Market Cap
18.37
P/E
14.52
Forward P/E
39
Score
ELV price $419.46 -2.02 -0.48%
Stocklytics score rationale: value 49, quality 37, growth 32.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 84978400000 | 90039400000 | 92105000000 | 104213000000 | 121867000000 | 138639000000 | 156595000000 | 171340000000 | 176810000000 | 199125000000 |
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical…
ELV fair value $619.12. Price $419.46. Price is 32% below fair value.
Below fair value, around its usual discount.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 6.51B. Growth 14.74%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 216.87M. Net debt 23.74B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-01-27 | — | 2.10 | — | 49.38B |
| 2026-10-21 | 6.99 | 4.71 | 50.44B | 49.28B |
| 2026-07-15 | 7.45 | 6.21 | 49.83B | 48.88B |
| 2026-04-22 | 12.58 | 10.82 | 49.49B | 48.20B |
| 2026-01-28 | 3.33 | 3.10 | 49.31B | 49.84B |
| 2025-10-21 | 6.03 | 4.93 | 50.09B | 49.38B |
| 2025-07-17 | 8.84 | 8.91 | 49.42B | 48.19B |
| 2025-04-22 | 11.97 | 11.41 | 48.77B | 46.30B |
| 2025-01-23 | 3.84 | 3.80 | 45.44B | 44.95B |
| 2024-10-17 | 8.37 | 9.66 | 45.15B | 43.47B |
| 2024-07-17 | 10.12 | 10.01 | 43.65B | 42.99B |
| 2024-04-18 | 10.64 | 10.53 | 42.58B | 42.49B |
| 2024-01-24 | 5.62 | 5.55 | 42.65B | 42.09B |
| 2023-10-18 | 8.99 | 8.45 | 42.85B | 41.97B |
| 2023-07-19 | 9.04 | 8.80 | 43.67B | 41.50B |
| 2023-04-19 | 9.46 | 9.26 | 42.17B | 40.83B |
| 2023-01-25 | 5.23 | 5.20 | 39.93B | 39.77B |
| 2022-10-19 | 7.53 | 7.15 | 39.94B | 39.29B |
| 2022-07-20 | 8.04 | 7.74 | 38.63B | 37.91B |
| 2022-04-20 | 8.25 | 7.81 | 38.09B | 37.39B |
| 2022-01-26 | 5.14 | 5.11 | 36.58B | 37.33B |
| 2021-10-20 | 6.79 | 6.37 | 35.82B | 35.30B |
| 2021-07-21 | 7.03 | 6.33 | 33.85B | 35.32B |
| 2021-04-21 | 7.01 | 6.51 | 32.38B | 29.90B |
| 2021-01-27 | 2.54 | 2.52 | 31.82B | 30.87B |
| 2020-10-28 | 4.20 | 4.15 | 31.16B | 30.79B |
| 2020-07-29 | 9.20 | 8.87 | 29.26B | 28.25B |
| 2020-04-29 | 6.48 | 6.48 | 29.62B | 29.62B |
| 2020-01-29 | 3.88 | 3.88 | 27.41B | 27.41B |
| 2019-10-23 | 4.87 | 4.82 | 26.67B | 26.40B |
| 2019-07-24 | 4.64 | 4.61 | 25.47B | 25.30B |
| 2019-04-24 | 6.03 | 5.81 | 24.67B | 23.77B |
| 2019-01-30 | 2.44 | 2.20 | 23.37B | 21.07B |
| 2018-10-31 | 3.81 | 3.70 | 23.25B | 22.58B |
| 2018-07-25 | 4.25 | 4.16 | 22.94B | 22.46B |
| 2018-04-25 | 5.41 | 4.88 | 22.54B | 20.33B |
| 2018-01-31 | 1.29 | 1.27 | 22.68B | 22.33B |
| 2017-10-25 | 2.65 | 2.42 | 22.43B | 20.48B |
| 2017-07-26 | 3.37 | 3.23 | 22.41B | 21.48B |
| 2017-04-26 | 4.68 | 3.86 | 22.53B | 18.58B |
Yield 1.64%. Payout ratio 29.17%. Frequency Quarterly.
Safety score 100/100 · Safe. Payout ratio is 29% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 16 separate years. Yield is 1.6%, in a range that is usually sustainable.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-12-04 | $1.72 | 2026-12-04 | 2026-12-18 | Quarterly |
| 2026-09-10 | $1.72 | 2026-09-10 | 2026-09-25 | Quarterly |
| 2026-06-10 | $1.72 | 2026-06-10 | 2026-06-25 | Quarterly |
| 2026-03-10 | $1.72 | 2026-03-10 | 2026-03-25 | Quarterly |
| 2025-12-05 | $1.71 | 2025-12-05 | 2025-12-19 | Quarterly |
| 2025-09-10 | $1.71 | 2025-09-10 | 2025-09-25 | Quarterly |
| 2025-06-10 | $1.71 | 2025-06-10 | 2025-06-25 | Quarterly |
| 2025-03-10 | $1.71 | 2025-03-10 | 2025-03-25 | Quarterly |
| 2024-12-05 | $1.63 | 2024-12-05 | 2024-12-20 | Quarterly |
| 2024-09-10 | $1.63 | 2024-09-10 | 2024-09-25 | Quarterly |
| 2024-06-10 | $1.63 | 2024-06-10 | 2024-06-25 | Quarterly |
| 2024-03-07 | $1.63 | 2024-03-08 | 2024-03-22 | Quarterly |
| 2023-12-05 | $1.48 | 2023-12-06 | 2023-12-21 | Quarterly |
| 2023-09-07 | $1.48 | 2023-09-08 | 2023-09-22 | Quarterly |
| 2023-06-08 | $1.48 | 2023-06-09 | 2023-06-23 | Quarterly |
| 2023-03-09 | $1.48 | 2023-03-10 | 2023-03-24 | Quarterly |
| 2022-12-02 | $1.28 | 2022-12-05 | 2022-12-21 | Quarterly |
| 2022-09-08 | $1.28 | 2022-09-09 | 2022-09-23 | Quarterly |
| 2022-06-09 | $1.28 | 2022-06-10 | 2022-06-24 | Quarterly |
| 2022-03-09 | $1.28 | 2022-03-10 | 2022-03-25 | Quarterly |
| 2021-12-02 | $1.13 | 2021-12-03 | 2021-12-21 | Quarterly |
| 2021-09-09 | $1.13 | 2021-09-10 | 2021-09-24 | Quarterly |
| 2021-06-09 | $1.13 | 2021-06-10 | 2021-06-25 | Quarterly |
| 2021-03-09 | $1.13 | 2021-03-10 | 2021-03-25 | Quarterly |
| 2020-12-04 | $0.95 | 2020-12-07 | 2020-12-22 | Quarterly |
| 2020-09-09 | $0.95 | 2020-09-10 | 2020-09-25 | Quarterly |
| 2020-06-09 | $0.95 | 2020-06-10 | 2020-06-25 | Quarterly |
| 2020-03-13 | $0.95 | 2020-03-16 | 2020-03-27 | Quarterly |
| 2019-12-04 | $0.80 | 2019-12-05 | 2019-12-20 | Quarterly |
| 2019-09-09 | $0.80 | 2019-09-10 | 2019-09-25 | Quarterly |
| 2019-06-07 | $0.80 | 2019-06-10 | 2019-06-25 | Quarterly |
| 2019-03-15 | $0.80 | 2019-03-18 | 2019-03-29 | Quarterly |
| 2018-12-04 | $0.75 | 2018-12-05 | 2018-12-21 | Quarterly |
| 2018-09-07 | $0.75 | 2018-09-10 | 2018-09-25 | Quarterly |
| 2018-06-07 | $0.75 | 2018-06-08 | 2018-06-25 | Quarterly |
| 2018-03-08 | $0.75 | 2018-03-09 | 2018-03-23 | Quarterly |
| 2017-12-04 | $0.70 | 2017-12-05 | 2017-12-21 | Quarterly |
| 2017-09-07 | $0.70 | 2017-09-08 | 2017-09-25 | Quarterly |
| 2017-06-07 | $0.65 | 2017-06-09 | 2017-06-23 | Quarterly |
| 2017-03-08 | $0.65 | 2017-03-10 | 2017-03-24 | Quarterly |
| 2016-12-01 | $0.65 | 2016-12-05 | 2016-12-21 | Quarterly |
| 2016-09-07 | $0.65 | 2016-09-09 | 2016-09-26 | Quarterly |
| 2016-06-08 | $0.65 | 2016-06-10 | 2016-06-24 | Quarterly |
| 2016-03-08 | $0.65 | 2016-03-10 | 2016-03-25 | Quarterly |
| 2015-12-02 | $0.62 | 2015-12-04 | 2015-12-21 | Quarterly |
| 2015-09-08 | $0.62 | 2015-09-10 | 2015-09-25 | Quarterly |
| 2015-06-08 | $0.62 | 2015-06-10 | 2015-06-25 | Quarterly |
| 2015-03-06 | $0.62 | 2015-03-10 | 2015-03-25 | Quarterly |
| 2014-12-03 | $0.44 | 2014-12-05 | 2014-12-22 | Quarterly |
| 2014-09-08 | $0.44 | 2014-09-10 | 2014-09-25 | Quarterly |
| 2014-06-06 | $0.44 | 2014-06-10 | 2014-06-25 | Quarterly |
| 2014-03-06 | $0.44 | 2014-03-10 | 2014-03-25 | Quarterly |
| 2013-12-05 | $0.38 | 2013-12-09 | 2013-12-23 | Quarterly |
| 2013-09-06 | $0.38 | 2013-09-10 | 2013-09-25 | Quarterly |
| 2013-06-06 | $0.38 | 2013-06-10 | 2013-06-25 | Quarterly |
| 2013-03-06 | $0.38 | 2013-03-08 | 2013-03-25 | Quarterly |
| 2012-12-05 | $0.29 | 2012-12-07 | 2012-12-21 | Quarterly |
| 2012-09-06 | $0.29 | 2012-09-10 | 2012-09-25 | Quarterly |
| 2012-06-06 | $0.29 | 2012-06-08 | 2012-06-25 | Quarterly |
| 2012-03-07 | $0.29 | 2012-03-09 | 2012-03-23 | Quarterly |
| 2011-12-07 | $0.25 | 2011-12-09 | 2011-12-23 | Quarterly |
| 2011-09-07 | $0.25 | 2011-09-09 | 2011-09-23 | Quarterly |
| 2011-06-08 | $0.25 | 2011-06-10 | 2011-06-24 | Quarterly |
| 2011-03-08 | $0.25 | 2011-03-10 | 2011-03-25 | Quarterly |
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-22 | Kaye Mark | Sell | 400 | $434.00 | 173.60K |
| 2026-10-22 | Kaye Mark | Sell | 321 | $435.25 | 139.72K |
| 2026-10-22 | Kaye Mark | Sell | 1.66K | $436.20 | 724.09K |
| 2026-10-22 | Kaye Mark | Sell | 560 | $437.07 | 244.76K |
| 2026-10-22 | Kaye Mark | Sell | 240 | $438.22 | 105.17K |
| 2026-10-22 | Kaye Mark | Sell | 1.16K | $439.25 | 509.53K |
| 2026-10-22 | Kaye Mark | Sell | 1.72K | $440.44 | 757.56K |
| 2026-10-22 | Kaye Mark | Sell | 2.34K | $441.34 | 1.03M |
| 2026-10-22 | Kaye Mark | Sell | 480 | $442.61 | 212.45K |
| 2026-10-22 | Kaye Mark | Sell | 440 | $443.81 | 195.28K |
| 2026-10-22 | Kaye Mark | Sell | 160 | $444.85 | 71.18K |
| 2026-10-22 | Kaye Mark | Sell | 827 | $446.05 | 368.88K |
| 2026-10-22 | Kaye Mark | Sell | 273 | $447.19 | 122.08K |
| 2026-10-02 | Kaye Mark | Buy | 2.63K | — | — |
| 2026-10-02 | Kaye Mark | Sell | 4.16K | $386.43 | 1.61M |
| 2026-09-03 | Wessling Erin M | Sell | 255 | $414.78 | 105.77K |
| 2026-09-02 | Wessling Erin M | Sell | 94 | $405.84 | 38.15K |
| 2026-09-02 | Craig Ryan R | Sell | 144 | $405.84 | 58.44K |
| 2026-07-17 | PERU RAMIRO G | Buy | 1.00K | $366.05 | 366.05K |
| 2026-07-17 | BOUDREAUX GAIL | Buy | 2.04K | $368.25 | 753.07K |
| 2026-07-17 | BOUDREAUX GAIL | Buy | 680 | $366.41 | 249.16K |
| 2026-06-12 | Penczek Ronald W | Sell | 369 | $403.16 | 148.77K |
| 2026-06-11 | Dixon Robert L JR | Sell | 151 | $401.77 | 60.67K |
| 2026-05-19 | Penczek Ronald W | Buy | 877 | $311.48 | 273.17K |
| 2026-05-19 | Penczek Ronald W | Buy | 654 | $271.27 | 177.41K |
| 2026-05-19 | Penczek Ronald W | Sell | 1.53K | $403.13 | 617.19K |
| 2026-05-19 | Penczek Ronald W | Sell | 654 | $271.27 | 177.41K |
| 2026-05-19 | Penczek Ronald W | Sell | 877 | $311.48 | 273.17K |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | Buy | 563 | — | — |
| 2026-05-13 | SCHULMAN AMY W | Buy | 563 | — | — |
| 2026-05-13 | Schneider Ryan M. | Buy | 563 | — | — |
| 2026-05-13 | PERU RAMIRO G | Buy | 563 | — | — |
| 2026-05-13 | Neri Antonio F | Buy | 563 | — | — |
| 2026-05-13 | Jallal Bahija | Buy | 563 | — | — |
| 2026-05-13 | HAY LEWIS III | Buy | 563 | — | — |
| 2026-05-13 | Dixon Robert L JR | Buy | 563 | — | — |
| 2026-05-13 | DeVore Susan D. | Buy | 563 | — | — |
| 2026-05-13 | COLLIS STEVEN H | Buy | 563 | — | — |
| 2026-03-12 | SCHULMAN AMY W | Sell | 26 | $287.50 | 7.47K |
| 2026-03-06 | Kendrick Charles Morgan JR | Sell | 3.20K | $284.92 | 910.60K |
| 2026-03-05 | COLLIS STEVEN H | Buy | 3.00K | $289.84 | 869.52K |
| 2026-03-03 | Penczek Ronald W | Sell | 37 | $284.03 | 10.51K |
| 2026-03-03 | Wessling Erin M | Sell | 417 | $284.03 | 118.44K |
| 2026-03-03 | Craig Ryan R | Sell | 309 | $284.03 | 87.77K |
| 2026-03-03 | Norwood Felicia F | Sell | 496 | $284.03 | 140.88K |
| 2026-03-03 | LAVU RATNAKAR | Sell | 222 | $284.03 | 63.05K |
| 2026-03-03 | Kendrick Charles Morgan JR | Sell | 467 | $284.03 | 132.64K |
| 2026-03-03 | Haytaian Peter D | Sell | 446 | $284.03 | 126.68K |
| 2026-03-03 | Kaye Mark | Sell | 353 | $284.03 | 100.26K |
| 2026-03-03 | BOUDREAUX GAIL | Sell | 1.74K | $284.03 | 493.08K |
| 2026-03-02 | Penczek Ronald W | Buy | 266 | — | — |
| 2026-03-02 | Penczek Ronald W | Buy | 1.70K | — | — |
| 2026-03-02 | Penczek Ronald W | Buy | 426 | — | — |
| 2026-03-02 | Penczek Ronald W | Sell | 131 | $294.07 | 38.52K |
| 2026-03-02 | Penczek Ronald W | Buy | 1.68K | $294.07 | 493.16K |
| 2026-03-02 | Wessling Erin M | Buy | 11.75K | $294.07 | 3.46M |
| 2026-03-02 | Wessling Erin M | Buy | 2.98K | — | — |
| 2026-03-02 | Craig Ryan R | Buy | 11.75K | $294.07 | 3.46M |
| 2026-03-02 | Craig Ryan R | Buy | 2.98K | — | — |
| 2026-03-02 | Craig Ryan R | Sell | 25 | $294.07 | 7.35K |
| 2026-03-02 | Norwood Felicia F | Buy | 2.87K | — | — |
| 2026-03-02 | Norwood Felicia F | Buy | 5.95K | — | — |
| 2026-03-02 | Norwood Felicia F | Sell | 1.42K | $294.07 | 417.87K |
| 2026-03-02 | Norwood Felicia F | Buy | 23.51K | $294.07 | 6.91M |
| 2026-03-02 | LAVU RATNAKAR | Buy | 20.15K | $294.07 | 5.93M |
| 2026-03-02 | LAVU RATNAKAR | Buy | 6.80K | — | — |
| 2026-03-02 | LAVU RATNAKAR | Buy | 5.10K | — | — |
| 2026-03-02 | LAVU RATNAKAR | Sell | 315 | $294.07 | 92.63K |
| 2026-03-02 | Kendrick Charles Morgan JR | Buy | 15.87K | $294.07 | 4.67M |
| 2026-03-02 | Kendrick Charles Morgan JR | Buy | 2.53K | — | — |
| 2026-03-02 | Kendrick Charles Morgan JR | Buy | 4.02K | — | — |
| 2026-03-02 | Kendrick Charles Morgan JR | Sell | 1.21K | $294.07 | 356.12K |
| 2026-03-02 | Haytaian Peter D | Buy | 2.87K | — | — |
| 2026-03-02 | Haytaian Peter D | Sell | 1.20K | $294.07 | 353.18K |
| 2026-03-02 | Kaye Mark | Buy | 10.20K | — | — |
| 2026-03-02 | Kaye Mark | Buy | 25.19K | $294.07 | 7.41M |
| 2026-03-02 | Kaye Mark | Buy | 6.38K | — | — |
| 2026-03-02 | Kaye Mark | Sell | 271 | $294.07 | 79.69K |
| 2026-03-02 | BOUDREAUX GAIL | Buy | 10.53K | — | — |
| 2026-03-02 | BOUDREAUX GAIL | Buy | 16.15K | — | — |
| 2026-03-02 | BOUDREAUX GAIL | Sell | 6.71K | $294.07 | 1.97M |
| 2026-03-02 | BOUDREAUX GAIL | Buy | 63.82K | $294.07 | 18.77M |
| 2026-02-02 | SCHULMAN AMY W | Buy | 218 | — | — |
| 2026-02-02 | Craig Ryan R | Sell | 279 | $341.83 | 95.37K |
| 2026-01-12 | SCHULMAN AMY W | Other | 0 | — | — |
| 2025-10-02 | Kaye Mark | Sell | 2.90K | $340.24 | 984.99K |
| 2025-09-03 | Wessling Erin M | Sell | 152 | $321.59 | 48.88K |
| 2025-09-02 | Wessling Erin M | Buy | 931 | — | — |
| 2025-09-02 | Wessling Erin M | Buy | 3.54K | $322.33 | 1.14M |
| 2025-09-02 | Craig Ryan R | Buy | 970 | — | — |
| 2025-09-02 | Craig Ryan R | Buy | 3.69K | $322.33 | 1.19M |
| 2025-08-19 | DeVore Susan D. | Buy | 1.20K | $312.15 | 374.58K |
| 2025-08-11 | Craig Ryan R | Other | 0 | — | — |
| 2025-08-11 | Wessling Erin M | Other | 0 | — | — |
| 2025-08-11 | Wessling Erin M | Other | 394 | $562.29 | 221.54K |
| 2025-08-11 | Wessling Erin M | Other | 1.92K | $395.50 | 760.15K |
| 2025-08-11 | Craig Ryan R | Other | 0 | — | — |
| 2025-08-11 | Craig Ryan R | Other | 965 | $499.11 | 481.64K |
| 2025-08-11 | Craig Ryan R | Other | 1.20K | $395.50 | 475.00K |
| 2025-08-01 | COLLIS STEVEN H | Buy | 639 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 1.68K, holders +154 vs prior quarter. Ownership 92.37%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 18.99M | -896.02K | -4.51% | 7.34B |
| VANGUARD CAPITAL MANAGEMENT LLC | 14.06M | -287.25K | -2.00% | 5.44B |
| STATE STREET CORP | 10.43M | 137.91K | +1.34% | 4.03B |
| WELLINGTON MANAGEMENT GROUP LLP | 9.21M | 984.98K | +11.97% | 3.56B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.21M | -141.72K | -2.23% | 2.40B |
| SANDERS CAPITAL, LLC | 5.83M | -69.28K | -1.18% | 2.25B |
| GEODE CAPITAL MANAGEMENT, LLC | 5.17M | -26.58K | -0.51% | 1.99B |
| HARRIS ASSOCIATES L P | 4.92M | 4.58M | +1348.39% | 1.90B |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 4.58M | -545.95K | -10.65% | 1.77B |
| INVESCO LTD. | 4.23M | -583.18K | -12.11% | 1.64B |
| FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 4.19M | 55.91K | +1.35% | 1.62B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.01M | -731.59K | -15.41% | 1.55B |
| NORGES BANK | 3.96M | 3.96M | New | 1.53B |
| BANK OF NEW YORK MELLON CORP | 3.22M | 377.51K | +13.27% | 1.25B |
| FMR LLC | 3.13M | 1.16M | +58.51% | 1.21B |
| MORGAN STANLEY | 2.61M | -23.34K | -0.89% | 1.01B |
| NORTHERN TRUST CORP | 2.11M | -43.04K | -1.99% | 817.93M |
| CITIGROUP INC | 2.10M | 2.10M | New | 810.92M |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 2.07M | -453.08K | -17.99% | 798.81M |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2.02M | -175.36K | -8.00% | 779.73M |
| GOLDMAN SACHS GROUP INC | 2.01M | 529.43K | +35.86% | 775.63M |
| NUVEEN, LLC | 1.99M | 29.16K | +1.49% | 769.54M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.94M | -300.25K | -13.43% | 749.42M |
| BANK OF AMERICA CORP /DE/ | 1.81M | -912.50K | -33.56% | 698.54M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.80M | 1.80M | New | 697.55M |
Elevance Health Inc. (ELV) trades at $419.46, with a market cap of $90.97B and a trailing P/E of 18.37. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 84978400000 | 90039400000 | 92105000000 | 104213000000 | 121867000000 | 138639000000 | 156595000000 | 171340000000 | 176810000000 | 199125000000 |
Insights · Dividends · Forecast · Financials · Learn
$90.97B
Market Cap
18.37
P/E
14.52
Forward P/E
39
Score